Lactiplantibacillus plantarum strain, culture medium derived therefrom, and antiallergic uses thereof
AssigneeGi Biome
InventorsMyung Ho JANG, Bo Gie YANG, A Ram KIM
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a novel microorganism, a lysate thereof, a culture broth thereof, and anti-allergy uses thereof, wherein a novel strain according to one aspect, a lysate derived from the strain, a culture broth of the strain, an extract of the culture broth, or a mixture thereof may be advantageously used in prevention, alleviation, or treatment of allergic diseases.
Claims22
1-29. (canceled)
A method of preventing or treating an allergic disease, the method comprising administering a composition comprising an effective amount of the Lactiplantibacillus plantarum GBCC_F0070 strain deposited under Accession No. KCTC15051BP, a culture of the strain, a lysate of the strain, or a mixture thereof, to a subject in need thereof.
(canceled)
A method of inhibiting the production of a Th2 (Helper T cells type 2)-mediated cytokine or alleviating an allergic reaction, the method comprising administering a composition comprising an effective amount of the Lactiplantibacillus plantarum GBCC_F0070 strain, a culture of the strain, a lysate of the strain, or a mixture thereof, to a subject in need thereof.
A method of alleviating or preventing an allergic skin condition, the method comprising administering a composition comprising the Lactiplantibacillus plantarum GBCC_F0070 strain, a lysate derived from the strain, a culture broth of the strain, or a mixture thereof.
Dependencies are inferred from the claim text.